New Delhi, December 3, 2020, Thursday
Research on various vaccines has become a silver lining among the growing cases of the corona virus around the world. Its human trials were also carried out by scientists and medical teams, which were said to have been successful. After Russia launched the Sputnik-V corona vaccine in August, India, along with the United States and Britain, was at the forefront of corona vaccine research. Dr Randeep Guleria, director of the All India Institute of Medical Sciences, hopes the emergency vaccine can be used in India later this month or early next month.
India has vaccines in the final stages of testing. They can be approved quickly. Once a booster dose is given, antibodies start to build up in the body. This will provide protection against Covid-15 for a long time. However, it remains to be seen how the vaccine will develop immunity. The vaccine is very safe given that India has so much data on vaccine research. The safety and potency of the vaccine cannot be compromised in any way. About 50 to 60 volunteers have been vaccinated to date. No one has a serious problem or side effect. During the Oxford AstraZeneca vaccine trial, a person from Chennai was accused of having side effects, but they are unrelated to the vaccine and the person may already have an illness.